TAKE A SEAT Trademark

Trademark Overview

On Friday, March 4, 2016, a trademark application was filed for TAKE A SEAT with the United States Patent and Trademark Office. The USPTO has given the TAKE A SEAT trademark a serial number of 86929628. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, May 24, 2023. This trademark is owned by Seres Therapeutics, Inc.. The TAKE A SEAT trademark is filed in the Advertising, Business and Retail Services category with the following description:

Recruiting services, namely, recruiting research subjects to participate in scientific studies and research [ in the ] in the fields of medicine, science, microbiology, health, and the prevention, treatment, and management of illness
take a seat

General Information

Serial Number86929628
Word MarkTAKE A SEAT
Filing DateFriday, March 4, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, May 24, 2023
Registration Number5312320
Registration DateTuesday, October 17, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2016

Trademark Statements

Goods and ServicesRecruiting services, namely, recruiting research subjects to participate in scientific studies and research [ in the ] in the fields of medicine, science, microbiology, health, and the prevention, treatment, and management of illness

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, March 10, 2016
Primary Code035
First Use Anywhere DateMonday, May 1, 2017
First Use In Commerce DateMonday, May 1, 2017

Trademark Owner History

Party NameSOCI�T� DES PRODUITS NESTL� S.A.
Party Type31 - New Owner After Registration
Legal Entity Type33 - NOT AVAILABLE
AddressVEVEY 1800
CH
Party NameSeres Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139
Party NameSeres Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139
Party NameSeres Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, March 8, 2016NEW APPLICATION ENTERED
Thursday, March 10, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 15, 2016ASSIGNED TO EXAMINER
Tuesday, May 24, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, April 20, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 4, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 24, 2016PUBLISHED FOR OPPOSITION
Tuesday, July 19, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 11, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 15, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 15, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 18, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, January 18, 2017SOU EXTENSION 1 FILED
Wednesday, January 18, 2017SOU EXTENSION 1 GRANTED
Friday, January 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 17, 2017TEAS STATEMENT OF USE RECEIVED
Monday, July 17, 2017USE AMENDMENT FILED
Wednesday, May 24, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 11, 2017STATEMENT OF USE PROCESSING COMPLETE
Sunday, September 10, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 12, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 17, 2017REGISTERED-PRINCIPAL REGISTER
Monday, October 17, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, November 10, 2022TEAS SECTION 8 & 15 RECEIVED
Wednesday, May 24, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, May 24, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, October 16, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

seat take research recruiting health microbiology prevention treatment illness management science fields